Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer ...

Even treated with the most advanced therapies, patients with glioblastoma—an aggressive brain cancer—typically survive less ...

Filippo Veglia, Ph.D., of Wistar’s Genome Regulation and Cell Signaling Program, discusses the most lethal form of brain cancer.

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

In a cell-based study, researchers have forced glioblastoma cells to display immune system targets, making them visible to ...